LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity
Shin Foong Ngiow(Parker Institute for Cancer Immunotherapy), Sasikanth Manne(Translational Therapeutics (United States)), Yinghui Huang(Parker Institute for Cancer Immunotherapy), Tarek Azar(University of Pennsylvania), Zeyu Chen(Translational Therapeutics (United States)), Divij Mathew(Parker Institute for Cancer Immunotherapy), Qingzhou Chen(University of Pennsylvania), Omar Khan(Translational Therapeutics (United States)), Jennifer E. Wu(Parker Institute for Cancer Immunotherapy), Víctor Alcalde(Translational Therapeutics (United States)), Ahron Flowers(University of Pennsylvania), Symone McClain(University of Pennsylvania), Amy E. Baxter(Translational Therapeutics (United States)), Makoto Kurachi(University of Pennsylvania), Junwei Shi(University of Pennsylvania), Alexander C. Huang(Parker Institute for Cancer Immunotherapy), Josephine R. Giles(Parker Institute for Cancer Immunotherapy), Arlene H. Sharpe(Brigham and Women's Hospital), Dario A.A. Vignali(University of Pittsburgh), E. John Wherry(Parker Institute for Cancer Immunotherapy)
Cited by 95Open Access
Abstract
Related Papers
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Yoshiko Iwai, Masayoshi Ishida, Yoshimasa Tanaka et al.|Proceedings of the National Academy of Sciences|2002|3.2k
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Lukas Baitsch, Petra Baumgaertner, Estelle Devêvre et al.|Journal of Clinical Investigation|2011|820